Tuğçe Nur Yiğenoğlu

641 total citations
65 papers, 303 citations indexed

About

Tuğçe Nur Yiğenoğlu is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Tuğçe Nur Yiğenoğlu has authored 65 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 20 papers in Oncology and 18 papers in Pathology and Forensic Medicine. Recurrent topics in Tuğçe Nur Yiğenoğlu's work include Hematopoietic Stem Cell Transplantation (19 papers), Lymphoma Diagnosis and Treatment (15 papers) and COVID-19 Clinical Research Studies (8 papers). Tuğçe Nur Yiğenoğlu is often cited by papers focused on Hematopoietic Stem Cell Transplantation (19 papers), Lymphoma Diagnosis and Treatment (15 papers) and COVID-19 Clinical Research Studies (8 papers). Tuğçe Nur Yiğenoğlu collaborates with scholars based in Türkiye, Cambodia and Antigua and Barbuda. Tuğçe Nur Yiğenoğlu's co-authors include Fevzi Altuntaş, Mehmet Sinan Dal, Semih Başçı, Mehmet Ali Erkurt, Serdal Korkmaz, Burhan Turgut, Tuba Hacıbekiroğlu, Sinem Namdaroğlu, Abdulkadir Baştürk and İlhami Berber and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and Journal of Medical Virology.

In The Last Decade

Tuğçe Nur Yiğenoğlu

49 papers receiving 299 citations

Peers

Countries citing papers authored by Tuğçe Nur Yiğenoğlu

Since Specialization

Citations

This map shows the geographic impact of Tuğçe Nur Yiğenoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuğçe Nur Yiğenoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuğçe Nur Yiğenoğlu more than expected).

Fields of papers citing papers by Tuğçe Nur Yiğenoğlu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tuğçe Nur Yiğenoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuğçe Nur Yiğenoğlu. The network helps show where Tuğçe Nur Yiğenoğlu may publish in the future.

Co-authorship network of co-authors of Tuğçe Nur Yiğenoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Tuğçe Nur Yiğenoğlu. A scholar is included among the top collaborators of Tuğçe Nur Yiğenoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tuğçe Nur Yiğenoğlu. Tuğçe Nur Yiğenoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias 2025 ·Bone Marrow Transplantation ·(unknown), Tayfur Toptaş, Mehmet Sinan Dal, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Tuğçe Nur Yiğenoğlu, Mehmet Ali Erkurt, Turgay Ulaş, Fevzi Altuntaş	1
2	What is the role of alpha-1 antitrypsin in the management of acute graft versus host disease? 2024 ·Transfusion and Apheresis Science ·Tuğçe Nur Yiğenoğlu, Mehmet Ali Erkurt, Simten Dağdaş, (unknown), İrfan Kuku, (unknown), (unknown), (unknown), Mehmet Sinan Dal, Emın Kaya, Serdal Korkmaz, Turgay Ulaş, Fevzi Altuntaş	0
3	Is there a relationship between vitamin D levels and graft versus host disease? 2024 ·Transfusion and Apheresis Science ·Tuğçe Nur Yiğenoğlu, (unknown), Sinem Namdaroğlu, Mehmet Ali Erkurt, (unknown), (unknown), Seda Güleç Yılmaz, (unknown), Mehmet Koca, (unknown), Mehmet Sinan Dal, Serdal Korkmaz, Turgay Ulaş, (unknown)	0
4	Is Ruxolitinib an Effective and Safe Therapy for Chronic Myeloproliferative Diseases? 2024 ·Acta Oncologica Turcica ·(unknown), (unknown), (unknown), (unknown), Tuğçe Nur Yiğenoğlu, (unknown), Mehmet Sinan Dal, Fevzi Altuntaş	1
5	What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation? 2024 ·Transfusion and Apheresis Science ·Turgay Ulaş, Sinem Namdaroğlu, (unknown), Mehmet Ali Erkurt, (unknown), Tuğçe Nur Yiğenoğlu, (unknown), (unknown), (unknown), (unknown), (unknown), Emın Kaya, (unknown), Abdulkadir Baştürk, Mehmet Sinan Dal, (unknown)	0
6	Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey 2023 ·Journal of Chemotherapy ·(unknown), Mehmet Sinan Dal, Tuğçe Nur Yiğenoğlu, (unknown), (unknown), Semih Başçı, (unknown), Serdal Korkmaz, (unknown), Murat Albayrak, Abdulkadir Baştürk, Düzgün Özatlı, Mehmet Hilmi Doğu, Tuba Hacıbekiroğlu, Merih Kızıl Çakar, Turgay Ulaş, (unknown), (unknown), Bülent Eser, Fevzi Altuntaş	2
7	Characteristics and Outcome of Patients with Chronic Myelomonocytic Leukemia: Experience of a Single Center 2023 ·Acta Oncologica Turcica ·(unknown), (unknown), (unknown), (unknown), Semih Başçı, Tuğçe Nur Yiğenoğlu, Merih Kızıl Çakar, Mehmet Sinan Dal, Fevzi Altuntaş	1
8	Covid-19 clinical course and blood groups: Turkish population-based study 2021 ·TURKISH JOURNAL OF MEDICAL SCIENCES ·(unknown), Naim Ata, (unknown), (unknown), Tuğçe Nur Yiğenoğlu, Serdal Korkmaz, Sinem Korkmaz, (unknown), (unknown), (unknown), (unknown), Kürşat Dal, (unknown), Burhan Turgut, (unknown), (unknown), Osman Çelik, (unknown), Şuayıp Birinci	7
9	Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients 2021 ·Journal of Chemotherapy ·(unknown), Mehmet Sinan Dal, (unknown), Olga Meltem Akay, Özgür Mehtap, (unknown), Fehmi Hindilerden, (unknown), Tuğçe Nur Yiğenoğlu, Semih Başçı, Merih Kızıl Çakar, (unknown), Serdal Korkmaz, Turgay Ulaş, Gülsüm Özet, Burhan Ferhanoğlu, Meliha Nalçacı, Fevzi Altuntaş	8
10	Molecular evaluation of mutations in acute myeloid leukemia patients from Turkey 2021 ·Medicine ·(unknown), Mehmet Sinan Dal, (unknown), (unknown), (unknown), (unknown), (unknown), Semih Başçı, Tahir Darçın, (unknown), (unknown), (unknown), (unknown), Tuğçe Nur Yiğenoğlu, Fevzi Altuntaş	0
11	Factors affecting survival in elderly patients with diffuse large B-Cell lymphoma 2021 ·Leukemia Research ·(unknown), Tuğçe Nur Yiğenoğlu, Semih Başçı, (unknown), (unknown), Tahir Darçın, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Fevzi Altuntaş	6
12	Does myeloma genetic have an effect on stem cell mobilization? 2021 ·Transfusion and Apheresis Science ·Semih Başçı, Tuğçe Nur Yiğenoğlu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mehmet Sinan Dal, Merih Kızıl Çakar, Fevzi Altuntaş	1
13	Second allogeneic stem cell transplantation in acute leukemia patients: single-centre experience 2020 ·SHILAP Revista de lepidopterología ·(unknown), Tuğçe Nur Yiğenoğlu, Semih Başçı, (unknown), (unknown), (unknown), Mehmet Sinan Dal, Merih Kızıl Çakar, Fevzi Altuntaş	0
14	Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience 2020 ·TURKISH JOURNAL OF MEDICAL SCIENCES ·(unknown), Semih Başçı, Mehmet Sinan Dal, Merih Kızıl Çakar, (unknown), Tuğçe Nur Yiğenoğlu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Tahir Darçın, (unknown), (unknown), Fevzi Altuntaş	4
15	The effect of serum vitamin B12, folate, ferritin levels and transferrin saturation on stem cell mobilization in allogeneic donors 2020 ·Transfusion and Apheresis Science ·Tuğçe Nur Yiğenoğlu, Semih Başçı, (unknown), (unknown), (unknown), (unknown), Tahir Darçın, (unknown), (unknown), (unknown), (unknown), Merih Kızıl Çakar, Mehmet Sinan Dal, Tuba Hacıbekiroğlu, Fevzi Altuntaş	1
16	Inferior prognosis in poor mobilizing myeloma patients 2020 ·Transfusion and Apheresis Science ·Tuğçe Nur Yiğenoğlu, Semih Başçı, (unknown), (unknown), (unknown), (unknown), Tahir Darçın, (unknown), (unknown), (unknown), Merih Kızıl Çakar, Mehmet Sinan Dal, Tuba Hacıbekiroğlu, Fevzi Altuntaş	5
17	SARS-CoV-2 Virüsü ile Enfekte Kritik Düzey Hastaların Tedavisinde Konvelesan (İmmun) Plazma Kullanımı 2020 ·DergiPark (Istanbul University) ·Tuba Hacıbekiroğlu, Tuğçe Nur Yiğenoğlu, (unknown)	0
18	The Outcome of Diffuse Large B Cell Lymphoma Patients in Adolescent and Young Adult Age Group 2020 ·Journal of Adolescent and Young Adult Oncology ·Semih Başçı, (unknown), Tuğçe Nur Yiğenoğlu, (unknown), (unknown), (unknown), Mehmet Sinan Dal, (unknown), Fevzi Altuntaş	2
19	Evaluation of Risk Factors for Mortality in Febrile Neutropenia 2020 ·The Journal of Infection in Developing Countries ·(unknown), Habip Gedık, (unknown), (unknown), (unknown), (unknown), Tuğçe Nur Yiğenoğlu, Fevzi Altuntaş, Berna Öksüzoğlu, Mustafa Ertek	6
20	Does microbial contamination influence the success of the hematopoietic cell transplantation outcomes? 2016 ·Transfusion and Apheresis Science ·Mehmet Sinan Dal, Emre Tekgündüz, Merih Kızıl Çakar, Ali Kaya, (unknown), (unknown), (unknown), (unknown), Tuğçe Nur Yiğenoğlu, (unknown), (unknown), Uğur Bilge, (unknown), (unknown), Fevzi Altuntaş	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact